This interim guidance has been produced by the British Paediatric Neurology Association (BPNA) prior to the formal guidance by NICE anticipated to be published in October 2019. It highlights the key questions specialist clinicians should address before considering prescribing cannabis based products along with guidance on appropriate dosage and treatment regimes.
Download guidance here